drugset / Trial / NCT00950794
Study of Salmeterol (SN408D) for Adult Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
To demonstrate the efficacy (non-inferiority) of Salmeterol 50mcg bid (100mcg/day), compared with Hokunalin (tulobuterol) tape 2mg once a day, in terms of improvement in pulmonary function (peak expiratory flow: PEF) in a randomized, double-blind, parallel-group comparative study in adult patients with bronchial asthma on ICS 400mcg/day of FP equivalent.
Timeline
- Start
- 2003-09
- Primary completion
- 2005-02
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salmeterol | Other / unclassified | 50 ug | — |
| Comparator | Tulobuterol | Small molecule | 2 mg | — |